Mandated enrollment into a high-deductible insurance plan delays the time it takes patients with diabetes to seek care for cardiovascular (macrovascular) disease-related symptoms, tests, and procedures, compared with those who remain on a low-deductible insurance plan, an observational, longitudinal study suggests.
“High-deductible plans, which require potential out-of-pocket spending of approximately $1000 to $7000 per person per year for most nonpreventive care, have become an increasingly common feature of US commercial health insurance,” Frank Wharam, MD, MPH, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, and colleagues observe in their article, published online November 19 in the Annals of Internal Medicine.
Read more at Medscape
Research Areas
You might also be interested in...
View all News-
Penn Medicine News: Penn Medicine Researchers Awarded $27.5 Million for Large Palliative Care Study
July 19, 2023 -
Being Patient: Dr. Emily Largent: Making Clinical Trials Better for Participants
March 7, 2023 -
CNN: Opinion: My Near-Death Experience Teaches a Lesson
January 26, 2023 -
ACP Hospitalist: Hospitalists Can Help Eliminate HCV
January 12, 2023 -
FOX29 Philadelphia: Local Doctor Details Cardiac Arrest, Predicts Recovery Process for Damar Hamlin
January 3, 2023 -
Physician's Weekly: Nudges to Clinicians & Patients Triples Statin Prescribing
December 20, 2022 -
Patient Care: Statin Prescribing in Primary Care Boosted with EHR Prompts Plus Patient Alerts
December 5, 2022 -
TCTMD: A Simple Nudge Moves the Needle on Statin Prescribing
December 2, 2022 -
HealthDay News: Clinician Nudge Ups Initiation of Statin Prescribing in Primary Care
December 1, 2022 -
Freakonomics MD: How to Save a Stranger’s Heart
March 17, 2022 -
The Philadelphia Inquirer: Cancer treatment tackles a new frontier: Chemo at home, even on the go
January 31, 2021 -
MedPage Today: New Audio-Only Telemedicine Bill; Chronic Illness, Mental Health Fuel Boom
December 28, 2020